ImmunologybioRxivPreprint
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
D. Planas, T. Bruel, L. Grzelak…·O. Schwartz
This study assesses the neutralization sensitivity of SARS-CoV-2 B.1.1.7 and B.1.351 variants compared to D614G using sera and nasal swabs, finding reduced efficacy against B.1.351 in some convalescent and vaccinated individuals.
DOI 10.1101/2021.02.12.430472